title: Regulation of angiogenesis-related prostaglandin f2alpha-induced genes in the bovine corpus luteum.
abstract: We recently compared prostaglandin F2alpha (PG)-induced global gene expression profiles in PG-refractory, bovine corpus luteum (CL) collected on Day 4 of the estrous cycle, versus PG-responsive, Day 11 CL. Transcriptome analyses led us to study the regulation of angiogenesis-related genes by PG and their functions in luteal endothelial cells (ECs). We found that PG regulated angiogenesis-modulating factors in a luteal stage-dependent way. A robust increase in FGF2 expression (mRNA and protein) occurred in the PG-refractory Day 4 CL promoting CL survival and function. Inhibitors of FGF2 action, thrombospondin 1 and 2, their receptor (CD36), and PTX3 were upregulated by PG specifically in Day 11 CL undergoing luteolysis. VEGF mRNA decreased 4 h post-PG in both Day 4 and Day 11 CL. The resulting destabilization of blood vessels in Day 11 CL is expected to weaken the gland and reduce its hormonal output. These genes were expressed in dispersed luteal ECs and steroidogenic cells; however, thrombospondin 1 and FGF2 were more abundant in luteal ECs. Expression of such genes and their ability to modulate FGF2 actions were investigated. Similar to its in vivo effect, PG, in vitro, stimulated the expression of thrombospondins and PTX3 genes in several luteal cell models. Importantly, these factors influenced the angiogenic properties of luteal ECs. FGF2 dose-dependently enhanced cell migration and proliferation, whereas thrombospondin 1 and PTX3 inhibited FGF2 actions in luteal ECs. Collectively, the data presented here suggest that, by tilting the balance between pro- and antiangiogenic factors, PG can potentially control the ability of the CL to resist or advance toward luteolysis.
authors.affiliation: Department of Animal Sciences, the Robert H. Smith Faculty of Agriculture, Food and Environment, the Hebrew University of Jerusalem, Rehovot, Israel.
authors.forename: Yulia
authors.initials: Y
authors.lastname: Zalman
authors.forename: Eyal
authors.initials: E
authors.lastname: Klipper
authors.forename: Svetlana
authors.initials: S
authors.lastname: Farberov
authors.forename: Mohan
authors.initials: M
authors.lastname: Mondal
authors.forename: Gabbine
authors.initials: G
authors.lastname: Wee
authors.forename: Joseph K
authors.initials: JK
authors.lastname: Folger
authors.forename: George W
authors.initials: GW
authors.lastname: Smith
authors.forename: Rina
authors.initials: R
authors.lastname: Meidan
mesh_terms: D000818:Animals; D002097:C-Reactive Protein / Q000235:genetics / Q000502:physiology; D002417:Cattle / Q000502:physiology*; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D003338:Corpus Luteum / Q000502:physiology*; D015237:Dinoprost / Q000494:pharmacology*; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000235:genetics / Q000502:physiology; D005786:Gene Expression Regulation / Q000187:drug effects* / Q000502:physiology; D008183:Luteal Phase / Q000502:physiology; D003341:Luteolysis / Q000502:physiology*; D023421:Models, Animal; D018919:Neovascularization, Physiologic / Q000502:physiology*; D000683:Serum Amyloid P-Component / Q000235:genetics / Q000502:physiology; D019700:Thrombospondin 1 / Q000235:genetics / Q000502:physiology; D019699:Thrombospondins / Q000235:genetics / Q000502:physiology; D000099153:Pentraxins; D000099262:Thrombospondin 2
chemical_list: D002097:C-Reactive Protein; D015237:Dinoprost; D016222:Fibroblast Growth Factor 2; D000683:Serum Amyloid P-Component; D019700:Thrombospondin 1; D019699:Thrombospondins; D000099153:Pentraxins; D000099262:Thrombospondin 2